[Reduced post-partum bleeding after treatment with sublingual misoprostol: a randomized double-blind clinical study in a developing country--secondary publication)]
- PMID: 16579891
[Reduced post-partum bleeding after treatment with sublingual misoprostol: a randomized double-blind clinical study in a developing country--secondary publication)]
Abstract
Post-partum haemorrhage is the most common cause of maternal death in third-world countries. The objective of this study was to evaluate whether routine administration of sublingual misoprostol, 600 g, reduces post-partum haemorrhage. Significantly fewer women in the misoprostol group experienced a loss of > or = 1,000 ml (11% vs. 17%; 0.66 (0.45-0.98)) or > or = 1,500 ml (2% vs. 8%; 0.28 (0.12-0.64)) of blood. We conclude that sublingual misoprostol reduces the frequency of severe post-partum haemorrhage.
Similar articles
-
Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial.BMJ. 2005 Oct 1;331(7519):723. doi: 10.1136/bmj.331.7519.723. BMJ. 2005. PMID: 16195287 Free PMC article. Clinical Trial.
-
Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial.Lancet. 2010 Jan 16;375(9710):217-23. doi: 10.1016/S0140-6736(09)61923-1. Epub 2010 Jan 6. Lancet. 2010. PMID: 20060162 Clinical Trial.
-
Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial.Lancet. 2010 Jan 16;375(9710):210-6. doi: 10.1016/S0140-6736(09)61924-3. Epub 2010 Jan 6. Lancet. 2010. PMID: 20060161 Clinical Trial.
-
Misoprostol for the prevention and treatment of postpartum haemorrhage.Best Pract Res Clin Obstet Gynaecol. 2008 Dec;22(6):1025-41. doi: 10.1016/j.bpobgyn.2008.08.005. Epub 2008 Sep 10. Best Pract Res Clin Obstet Gynaecol. 2008. PMID: 18786863 Review.
-
Prevention of postpartum hemorrhage with misoprostol.Int J Gynaecol Obstet. 2007 Dec;99 Suppl 2:S198-201. doi: 10.1016/j.ijgo.2007.09.012. Epub 2007 Oct 24. Int J Gynaecol Obstet. 2007. PMID: 17961574 Review.
Cited by
-
Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects.Bull World Health Organ. 2009 Sep;87(9):666-77. doi: 10.2471/blt.08.055715. Bull World Health Organ. 2009. PMID: 19784446 Free PMC article.
-
Prostaglandins for preventing postpartum haemorrhage.Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD000494. doi: 10.1002/14651858.CD000494.pub4. Cochrane Database Syst Rev. 2012. PMID: 22895917 Free PMC article.
-
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD011689. doi: 10.1002/14651858.CD011689.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2018 Dec 19;12:CD011689. doi: 10.1002/14651858.CD011689.pub3. PMID: 29693726 Free PMC article. Updated.
-
Postpartum misoprostol for preventing maternal mortality and morbidity.Cochrane Database Syst Rev. 2013 Jul 15;2013(7):CD008982. doi: 10.1002/14651858.CD008982.pub2. Cochrane Database Syst Rev. 2013. PMID: 23857523 Free PMC article.
-
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.Cochrane Database Syst Rev. 2018 Dec 19;12(12):CD011689. doi: 10.1002/14651858.CD011689.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2025 Apr 16;4:CD011689. doi: 10.1002/14651858.CD011689.pub4. PMID: 30569545 Free PMC article. Updated.